Seven Grand Managers LLC
-6.64%
3M Return
$11.510
-0.216 (-1.88%)收盤時
Lumexa Imaging Holdings, Inc. is a national provider of diagnostic imaging services. The Company offers a range of advanced imaging services (MRI, CT and PET scans) and routine diagnostic and screening imaging services (X-ray, ultrasound and mammography). The Company’s segments include Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The Outpatient segment consists of imaging centers that are owned or operated by it (either wholly owned or via unconsolidated affiliate), where it performs the imaging scan and provides the radiologist’s interpretation service. The Professional segment consists of professional interpretation services, where the imaging scan itself is performed at the hospital or point of care and not by it or its unconsolidated affiliates. The Company and its affiliates operate outpatient imaging center footprint in the United States, spanning 184 centers across 13 states and includes eight joint venture partnerships with health systems.
Lumexa Imaging Holdings, Inc. is currently not a strong buy due to a recent RSI of 38.778 indicating oversold conditions, alongside a significant year-to-date change of -34.42%. However, the company has shown improvement in profitability with a net income of $2.7 million in Q2 2026, suggesting potential for recovery. The main risk is the high debt level, with a debt-to-equity ratio of 144.68%, which could impact financial stability.

Lumexa Imaging Reports Strong Q2 Revenue Growth and Strategic Developments

Lumexa Imaging Holdings Reports Q1 2026 Earnings Highlights

Lumexa Imaging Q1 Earnings Beat Expectations

Lumexa Imaging to Release Q1 2026 Financial Results

Johnson Fistel Investigates Lumexa Imaging for Potential Investor Claims
Lumexa Imaging Holdings, Inc. is a national provider of diagnostic imaging services. The Company offers a range of advanced imaging services (MRI, CT and PET scans) and routine diagnostic and screening imaging services (X-ray, ultrasound and mammography). The Company’s segments include Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The Outpatient segment consists of imaging centers that are owned or operated by it (either wholly owned or via unconsolidated affiliate), where it performs the imaging scan and provides the radiologist’s interpretation service. The Professional segment consists of professional interpretation services, where the imaging scan itself is performed at the hospital or point of care and not by it or its unconsolidated affiliates. The Company and its affiliates operate outpatient imaging center footprint in the United States, spanning 184 centers across 13 states and includes eight joint venture partnerships with health systems. It operates in the Healthcare sector.
Lumexa Imaging Holdings, Inc. is currently not a strong buy due to a recent RSI of 38.778 indicating oversold conditions, alongside a significant year-to-date change of -34.42%. However, the company has shown improvement in profitability with a net income of $2.7 million in Q2 2026, suggesting potential for recovery. The main risk is the high debt level, with a debt-to-equity ratio of 144.68%, which could impact financial stability.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。